Hints and tips:
Related Topics
...Terumo was granted exclusive distribution rights in 2017....
...The price/earnings ratio of Edwards Lifesciences and Terumo are a third higher. Even a small refocusing of Olympus’s image could lead to handsome gains....
...Olympus’s shares jumped 9.7 per cent on Thursday after Terumo revealed its interest, though they remain about 40 per cent below their pre-scandal level. Olympus declined to comment on Terumo’s offer....
...They sold Gambro Healthcare to the private equity fund Bridgepoint in 2007 for an enterprise value of SKr6.1bn while CaridianBCT was bought by the Japanese medical technology company Terumo Corporation in...
...Olympus shares jumped 9.6 per cent to Y1,400, while Terumo fell 0.8 per cent to Y3,070....
...Terumo said suing Olympus for damages was “a painful decision but the right thing to do” given the roughly Y8bn of losses it had suffered....
...Olympus gained 1.3 per cent to Y1,465, while Terumo climbed 0.8 per cent to Y3,150....
...Last February, Fujifilm acquired two biopharmaceutical companies from Merck, while Terumo acquired a US medical device company this January....
...Sony is understood to have approached the company, as have at least two other bidders: Terumo, a specialist medical equipment group, and Fujifilm, the optical devices maker....
...The Terumo deal is slated for completion next month and CaridianBCT will continue to be headed by David Perez....
...“It is a bit for show, but it gives the sense that we have maintained the culture of quality,” says Terumo Expo manager Masashi Yoshikawa....
...Elsewhere, medical equipment maker Terumo rose 6.4 per cent to Y2,980 after US Edwards Lifesciences said it would sell its cardiopulmonary products to the Japanese maker for US$10m-US$20m....
...Elsewhere, medical equipment maker Terumo rose 6.4 per cent to Y2,980 after US Edwards Lifesciences said it would sell its cardiopulmonary products to the Japanese maker for US$10-20m....
International Edition